What should we do about overweight and obesity?

---

• 1.
• McLennan W, Podger A. National Nutrition Survey -- Selected Highlights Australia. Canberra: Australian Bureau of Statistics and Department of Health and Family Services, 1997.
• 2.
• Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity, Geneva, 3-5 June, 1997. WHO: Geneva, 1997.
• 3.
• National Health and Medical Research Council. Acting on Australia's weight. The Report of the NHMRC Working Party on the prevention of overweight and obesity. Canberra: NHMRC, 1996.
• 4.
• Dupen F, Bauman A, Lin R. The source of risk factor information for general practitioners: is physical activity under-recognised? Med J Aust 1999; 171: 601-603.
• 5.
• Physical activity and health: a report of the Surgeon General. Atlanta, Md: US Department of Health and Human Services, Centers for Disease Control, 1996.
• 6.
• National Physical Activity Guidelines for Australians. Canberra: Commonwealth Department of Health and Aged Care, 1999.
• 7.
• Wing RR, Greeno CG. Behavioural and psychosocial aspects of obesity. Clin Endocrinol Metab 1994; 8: 689-703.
• 8.
• Egger G, Cameron-Smith D, Stanton R. The effectiveness of popular, non- prescription weight loss supplements. Med J Aust 1999; 171: 604-608.
• 9.
• Burry JN. Obesity and virtue. Is staying lean a matter of ethics? Med J Aust 1999; 171: 609-610.
• 10.
• Proietto J. Why staying lean is not a matter of ethics. Med J Aust 1999; 171: 611-613.
• 11.
• Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes 1991; 16: 397-415.
• 12.
• Sjostrom L, Rissanen A, Andersen T, et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 1998; 352: 167-172.
• 13.
• McNeely W, Goa KL. Sibutramine. A review of its contribution to management. Drugs 1998; 56: 1093-1124.
• 14.
• Egger G, Swinburn B. An "ecological" approach to the obesity pandemic. BMJ 1997; 315: 477-480.